Biotech company Puleva Biotech saw Q1 net profit increased to €250,000 (US$224,800) from €14,000 a year ago.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The biotech arm of Spanish food company Ebro Puleva revealed on Friday that pretax profit in the Q1 rose to €357,000 from €40,000 a year ago, while revenue was up at €925,000 from €538,000 in the first three months of 2001.
This is the first time that Puleva Biotech has released Q1 earnings figures since first listing in December.